更年期関連の市場規模、シェア、成長分析、治療法別、製品タイプ別、適応症別、流通上の課題別、年齢層別、地域別 - 産業予測 2025～2032年

更年期関連の世界市場規模は2023年に186億米ドルとなり、予測期間（2025-2032年）のCAGRは6.0%で、2024年の197億2,000万米ドルから2032年には314億2,000万米ドルに成長する見通しです。

更年期関連市場は、かなりの割合の女性が経験するほてり、寝汗、気分の落ち込みなどの更年期症状を緩和する製品に対する意識の高まりと需要を反映して、上昇基調にあります。45歳から55歳に及ぶこの自然な生物学的変化は、症状を和らげるように設計された栄養補助食品、ハーブ製品、市販薬への関心を急増させました。この成長を後押ししている要因には、人口の高齢化、健康意識の高まり、自然でオーガニックな解決策へのシフトなどがあります。COVID-19の大流行はこうした動向をさらに強め、精神衛生を乱し、女性にホルモン補充療法に代わる安全な植物由来の代替品を求めるよう促し、栄養補助食品の使用量を押し上げる結果となりました。この進化する情勢は、持続的な市場拡大の機会を示唆しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

更年期関連市場規模：治療法別& CAGR（2025-2032）

• 市場概要
• 栄養補助食品
• 市販薬
  • ホルモン製品
  • エストロゲンと他の薬剤の併用
  • エストロゲンとプロゲスチンの併用薬
  • エストロゲンのみの薬
  • プロゲスチンのみの薬
  • 非ホルモン製品

更年期関連市場規模：製品タイプ別& CAGR（2025-2032）

• 市場概要
• ゲル
• 注射
• 経口投与量
• パッチ
• ピル
• 粉
• スキンクリーム
• スキンスプレー（経皮）
• 膣クリーム
• 膣リング

更年期関連市場規模：適応症別& CAGR（2025-2032）

• 市場概要
• ドライアイ
• 乾燥肌
• ほてり
• 気分のむら軽いうつイライラ
• 寝汗と寒気
• 骨粗鬆症
• 睡眠障害
• 尿意切迫感
• 膣の乾燥

更年期関連市場規模：流通上の課題別& CAGR（2025-2032）

• 市場概要
• 病院薬局
• オンラインストア
• 小売薬局

更年期関連市場規模：年齢層別& CAGR（2025-2032）

• 市場概要
• 時期尚早な更年期
• 初期更年期
• 平均的な更年期
• 後期更年期

更年期関連市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• AbbVie Inc.（USA）
• Astellas Pharma Inc.（Japan）
• Bayer AG（Germany）
• Pfizer Inc.（USA）
• Novartis AG（Switzerland）
• Merck & Co., Inc.（USA）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Eli Lilly and Company（USA）
• GlaxoSmithKline plc（UK）
• Key Developments
• Mithra Pharmaceuticals（Belgium）
• Dr. Reddy's Laboratories Ltd.（India）
• Procter & Gamble（USA）
• Unilever（UK）
• Pure Encapsulations, LLC（USA）
• Rainbow Light（USA）
• Kindra（USA）
• Elektra Health（USA）

結論と提言

Global Menopause Market size was valued at USD 18.6 billion in 2023 and is poised to grow from USD 19.72 billion in 2024 to USD 31.42 billion by 2032, growing at a CAGR of 6.0% during the forecast period (2025-2032).

The menopause market is on an upward trajectory, reflecting heightened awareness and demand for products that alleviate menopausal symptoms such as hot flashes, night sweats, and mood swings, experienced by a significant percentage of women. Spanning ages 45 to 55, this natural biological transition has prompted a surge in interest for nutritional supplements, herbal products, and over-the-counter medications designed to ease symptoms. Factors fueling this growth include an aging population, increased health consciousness, and a shift toward natural and organic solutions. The COVID-19 pandemic has further intensified these trends, disrupting mental health and prompting women to seek safe, plant-based alternatives to hormone replacement therapy, resulting in a boost in dietary supplement usage. This evolving landscape signals sustained market expansion opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Menopause market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Menopause Market Segments Analysis

Global Menopause Market is segmented by Treatment, Product Type, Indication, Distribution Challenge, Age Group and region. Based on Treatment, the market is segmented into Dietary Supplements and OTC Pharma Products. Based on Product Type, the market is segmented into Gel, Injection, Oral Dosage, Patch, Pill, Powder, Skin Cream, Skin Spray (Transdermal), Vaginal Cream and Vaginal Ring. Based on Indication, the market is segmented into Dry Eyes, Dry Skin, Hot Flashes, Mood Swings, Mild depression & Irritability, Night Sweats and Cold Flashes., Osteoporosis, Trouble Sleeping, Urinary Urgency and Vaginal Dryness. Based on Distribution Challenge, the market is segmented into Hospital Pharmacies, Online Stores and Retail Pharmacies. Based on Age Group, the market is segmented into Premature Menopause, Early Menopause, Average Menopause and Late Menopause. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Menopause Market

The global menopause market is fueled by several key factors, including the aging population, increased awareness, lifestyle changes, and advancements in technology. As life expectancies rise and birth rates decline, more women are entering menopause, creating a substantial demand for menopause-related products and services. For example, the North American Menopause Association reports that about 2 million women in the U.S. go through menopause each year. Additionally, public awareness of menopause symptoms is improving, leading to greater demand for solutions like hormone therapy, herbal supplements, and wellness products. Women are also acknowledging the role of healthy lifestyles in managing menopause symptoms, further driving market growth.

Restraints in the Global Menopause Market

Despite the substantial growth potential in the Global Menopause market, several factors may act as constraints on its expansion. Safety concerns regarding hormone replacement therapy (HRT), particularly its links to increased risks of breast cancer, heart disease, and stroke, are paramount. Consequently, there is a growing demand for non-hormonal alternatives, creating challenges for companies focusing on hormone-based therapies to address these safety issues. Additionally, menopause remains a stigmatized topic in many cultures, leading to a lack of awareness and understanding that can suppress consumer demand and complicate marketing efforts for menopause-related products. Regulatory hurdles impose strict safety and efficacy requirements, further deterring innovation in treatment options. Compounded by insufficient research and development in this field, these factors collectively threaten to hinder the market's advancement.

Market Trends of the Global Menopause Market

The Global Menopause market is witnessing a significant shift towards non-hormonal therapies driven by women's growing apprehension regarding hormone-based treatments and their associated risks. This trend has led to a rising demand for alternative solutions, such as herbal medicines, cognitive-behavioral therapy (CBT), and mindfulness-based interventions, which are perceived as safer options for managing menopausal symptoms. As awareness around holistic health and wellness increases, healthcare providers and companies are focusing on developing and promoting these non-hormonal alternatives, further shaping the market landscape. This evolution highlights a consumer preference for natural and integrative approaches, signaling a transformative era in menopause management strategies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Menopause Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Dietary Supplements
• OTC Pharma Products
  • Hormonal products
  • Combination Estrogen and Other Medicines
  • Combination Estrogen and Progestin Medicines
  • Estrogen-Only Medicines
  • Progestin-Only Medicines
  • Non-hormonal products

Global Menopause Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Gel
• Injection
• Oral Dosage
• Patch
• Pill
• Powder
• Skin Cream
• Skin Spray (Transdermal)
• Vaginal Cream
• Vaginal Ring

Global Menopause Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Dry Eyes
• Dry Skin
• Hot Flashes
• Mood Swings, Mild depression & Irritability
• Night Sweats and Cold Flashes.
• Osteoporosis
• Trouble Sleeping
• Urinary Urgency
• Vaginal Dryness

Global Menopause Market Size by Distribution Challenge & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Online Stores
• Retail Pharmacies

Global Menopause Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• Premature Menopause
• Early Menopause
• Average Menopause
• Late Menopause

Global Menopause Market Size & CAGR (2025-2032)

• North America (Treatment, Product Type, Indication, Distribution Challenge, Age Group)
  • US
  • Canada
• Europe (Treatment, Product Type, Indication, Distribution Challenge, Age Group)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment, Product Type, Indication, Distribution Challenge, Age Group)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment, Product Type, Indication, Distribution Challenge, Age Group)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment, Product Type, Indication, Distribution Challenge, Age Group)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astellas Pharma Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• Mithra Pharmaceuticals (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Procter & Gamble (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Unilever (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pure Encapsulations, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rainbow Light (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kindra (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elektra Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations